Chapter title |
Gene Therapeutic Delivery to the Salivary Glands.
|
---|---|
Chapter number | 766 |
Book title |
Cell Biology and Translational Medicine, Volume 20
|
Published in |
Advances in experimental medicine and biology, February 2023
|
DOI | 10.1007/5584_2023_766 |
Pubmed ID | |
Book ISBNs |
978-3-03-141687-3, 978-3-03-141688-0
|
Authors |
Upadhyay, Akshaya, Cao, Uyen M N, Hariharan, Arvind, Almansoori, Akram, Tran, Simon D, Cao, Uyen M. N., Tran, Simon D. |
Abstract |
The salivary glands, exocrine glands in our body producing saliva, can be easily damaged by various factors. Radiation therapy and Sjogren's syndrome (a systemic autoimmune disease) are the two main causes of salivary gland damage, leading to a severe reduction in patients' quality of life. Gene transfer to the salivary glands has been considered a promising approach to treating the dysfunction. Gene therapy has long been applied to cure multiple diseases, including cancers, and hereditary and infectious diseases, which are proven to be safe and effective for the well-being of patients. The application of this treatment on salivary gland injuries has been studied for decades, yet its clinical progress is delayed. This chapter provides a coup d'oeil into gene transfer methods and various gene/vector types for salivary glands to help the new scientists and update established scientists on the progress that has been made during the past decades for the treatment of salivary gland disorders. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 1 | 20% |
Student > Bachelor | 1 | 20% |
Other | 1 | 20% |
Unknown | 2 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 2 | 40% |
Unknown | 3 | 60% |